Parallel Bio: Valuation, Funding & Investors
Parallel Bio is a privately held biotechnology company focused on discovering and developing novel therapeutics. The company applies experimental biology, target identification, and preclinical development to translate biological insights into drug candidates for human disease.
Leadership & Board
- Current Number of Employees
- 22
- Current LinkedIn Followers
- 5,407
Latest Estimated Valuation
- Total Amount Raised
- $21M
- Total Funding Rounds
- 1
- Latest Funding Amount
- $21M
- Latest Funding Round
- Series A
Employee Trend
Parallel Bio had 22 employees as of November 16, 2026. The number of employees increased by 0 (0.00%) week-over-week.
22Latest Employee Count
0(0.00%)Week-Over-Week Change
Social Trend
Parallel Bio had 5,407 followers as of November 16, 2026. The number of followers increased by 33 (0.61%) week-over-week.
5,407Latest Followers Count
33(0.61%)Week-Over-Week Change
Funding Round
| Funding Date | Funding Round | Amount Raised | Post-Money Valuation |
|---|---|---|---|
| Jul 11, 2025 | Series A | $21.00M | ― |
Investors
| Investor Name | Funding Round |
|---|---|
| AIX Ventures | Series A |
Similar Companies
A snapshot of private companies similar to Parallel Bio, helping you discover and navigate related company profiles.
Related News and Analysis







